We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
+4.27%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$56.6B
AUM Growth
-$4.33B
(-7.1%)
Cap. Flow
-$5.51B
Cap. Flow
% of AUM
-9.73%
Top 10 Holdings %
Top 10 Hldgs %
36.93%
Holding
1,739
New
42
Increased
177
Reduced
1,384
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$201M |
| 2 |
Oracle
ORCL
|
+$135M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$123M |
| 4 |
Invesco MSCI USA ETF
PBUS
|
+$80.7M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$63M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$267M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$183M |
| 3 |
NVIDIA
NVDA
|
+$172M |
| 4 |
JPMorgan Chase
JPM
|
+$137M |
| 5 |
Apple
AAPL
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.12% |
| 2 | Financials | 12.63% |
| 3 | Healthcare | 12.38% |
| 4 | Communication Services | 10.27% |
| 5 | Consumer Discretionary | 9.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
Qfin Holdings
QFIN
$1.69B
| $120K | ﹤0.01% |
6,250
| – | – |
|
1527
Recursion Pharmaceuticals
RXRX
$1.61B
| $120K | ﹤0.01% |
29,264
-380,672
| -93% | -$1.89M |
|
1528
Seadrill
SDRL
$2.54B
| $119K | ﹤0.01% |
3,451
-219
| -6% | -$6.82K |
|
1529
Iridium Communications
IRDM
$4.78B
| $119K | ﹤0.01% |
6,869
-16,250
| -70% | -$287K |
|
1530
LeMaitre Vascular
LMAT
$2.39B
| $119K | ﹤0.01% |
1,471
-4,850
| -77% | -$418K |
|
|
APLS
1531
DELISTED
Apellis Pharmaceuticals
APLS
| $119K | ﹤0.01% |
4,747
-11,800
| -71% | -$277K |
|
1532
Kemper
KMPR
$1.81B
| $119K | ﹤0.01% |
2,937
-7,450
| -72% | -$319K |
|
1533
Sprout Social
SPT
$535M
| $119K | ﹤0.01% |
10,551
-11,650
| -52% | -$126K |
|
1534
SolarEdge
SEDG
$2.47B
| $118K | ﹤0.01% |
4,091
-8,000
| -66% | -$279K |
|
1535
Gibraltar Industries
ROCK
$1.32B
| $118K | ﹤0.01% |
2,384
-3,800
| -61% | -$218K |
|
1536
Cannae Holdings
CNNE
$659M
| $118K | ﹤0.01% |
7,480
-19,500
| -72% | -$332K |
|
|
SEZL
1537
Sezzle
SEZL
$5.24B
| $117K | ﹤0.01% |
1,850
-2,750
| -60% | -$187K |
|
1538
Kulicke & Soffa
KLIC
$4.44B
| $117K | ﹤0.01% |
2,570
-3,850
| -60% | -$163K |
|
1539
ScottsMiracle-Gro
SMG
$4.12B
| $117K | ﹤0.01% |
1,998
-7,750
| -80% | -$435K |
|
1540
Gentherm
THRM
$1.32B
| $116K | ﹤0.01% |
3,179
-5,600
| -64% | -$202K |
|
1541
Enovix
ENVX
$860M
| $115K | ﹤0.01% |
15,735
-25,950
| -62% | -$251K |
|
1542
Innoviva
INVA
$1.59B
| $115K | ﹤0.01% |
+5,750
| New | +$112K |
|
1543
Concentrix
CNXC
$1.62B
| $114K | ﹤0.01% |
2,737
-5,950
| -68% | -$241K |
|
1544
BioCryst Pharmaceuticals
BCRX
$2.46B
| $112K | ﹤0.01% |
14,400
-32,400
| -69% | -$234K |
|
1545
F&G Annuities & Life
FG
$3.96B
| $112K | ﹤0.01% |
+3,633
| New | +$114K |
|
1546
TriNet
TNET
$3.28B
| $112K | ﹤0.01% |
1,888
-2,600
| -58% | -$154K |
|
1547
Pennant Group
PNTG
$1.44B
| $111K | ﹤0.01% |
3,938
-7,700
| -66% | -$205K |
|
1548
Tandem Diabetes Care
TNDM
$1.25B
| $111K | ﹤0.01% |
5,032
-12,150
| -71% | -$219K |
|
1549
Shoals Technologies Group
SHLS
$1.39B
| $110K | ﹤0.01% |
12,973
-23,000
| -64% | -$207K |
|
1550
ICF International
ICFI
$1.51B
| $110K | ﹤0.01% |
1,289
-2,700
| -68% | -$229K |
|
Similar funds
SCP
Ensign Peak Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, Ensign Peak Advisors held 1,739 positions worth $56.6B, down 7.1% from $60.9B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Ensign Peak Advisors withdrew a net $5.51B in Q4 2025, closing 54 positions and reducing 1,384 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $125M position sold in full.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Ensign Peak Advisors opened a new position in Invesco MSCI USA ETF worth $81.3M.
- Ensign Peak Advisors's largest Q4 2025 buy was Invesco MSCI USA ETF: 1,188,232 shares worth $81.3M.
- Ensign Peak Advisors added most to Eli Lilly in Q4 2025, an estimated $201M increase.
- Ensign Peak Advisors's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $267M.
- Ensign Peak Advisors fully exited iShares Core S&P 500 ETF in Q4 2025, selling an estimated $125M.
- Ensign Peak Advisors's ten largest holdings make up 37% of its $56.6B portfolio in Q4 2025.
- Ensign Peak Advisors opened 42 new positions and closed 54 in Q4 2025.
- Ensign Peak Advisors's portfolio value fell 7.1% quarter-over-quarter to $56.6B.
Based on Ensign Peak Advisors's 13F filing for Q4 2025, filed 12 Feb 2026.